Studying the Extra Benefits of Using Akulyadi Yog with Metformin to Treat Type 2 Diabetes

Clinical Study of Add On Effect Of Akulyadi Yog Along with Metformin in the Management of Prameha (NIDDM) - Nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/05/087402

Enrollment

Registered

2025-05-22

Start date

Unknown

Completion date

Unknown

Last updated

2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complications

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Age group in between 18 60 years Participants having classical signs and symptoms of prameha Participants of any gender religion and socioechonomic status. Participants already on Tablet Metformin 500mg HbA1C- from 6.5-9% Blood Sugar level Fasting -150-250mg/dl Post Prandial - 250-450mg/dl

Exclusion criteria

Exclusion criteria: Known case of type I diabetes mellitus Gestational Diabetes Participants having other complicated systematic disorders like diabetic ketoacidosis, nephropathy, Heart disease etc Participant on insulin or steroid treatment Pregnant and lactating Women Blood sugar level Fasting more than 250 Post Prandial more than 450

Design outcomes

Primary

Measure	Time frame
Reduction in Fasting and Post Prandial blood sugar levels.Timepoint: with gap of every 15days for 3months	—

Secondary

Measure	Time frame
Reduction in HbA1C Values and glycemic control in diabetic patientsTimepoint: 90 days	—

Countries

India

Contacts

Public ContactVd Priyanka Ganesh Minagule

Tilak Ayurved Mahavidyalaya and Seth Tarachand Ramnath Charitable Ayurvedic Hospital

sangeetap14@gmail.com9130774107

Outcome results